Menopause Before 40 Tracks With 40% Higher Lifetime Heart Risk

For most American women menopause arrives around 51, late enough that it registers as a life stage rather than a diagnosis. For a smaller group it arrives before 40, and that is a different proposition. As Priya Freaney, the Northwestern cardiologist who led the analysis published in JAMA Cardiology in March, frames it: when menopause happens before 40, women "still have more than half of their life expectancy ahead of them." Her team set out to measure what that long remaining window does to the heart.

The study pooled individual-level data from six long-running American cohorts — among them the Framingham Heart Study, the Atherosclerosis Risk in Communities study and the Women's Health Initiative — through the Cardiovascular Disease Lifetime Risk Pooling Project. It followed 10,036 postmenopausal women, 3,522 Black and 6,514 White, who were between 55 and 69 when they entered (mean ages 61.2 and 60.0) and free of coronary heart disease at that point. Menopause was dated to one year after the final menstrual period, and women whose menopause was surgical were excluded, so the exposure is natural early menopause only. Across 163,600 person-years spanning 1964 to 2018, the researchers counted fatal and nonfatal heart attacks — more than a thousand of them.

After adjustment for age, education, smoking, obesity, hypertension and diabetes, women with premature menopause carried a hazard ratio of 1.41 (95% CI, 1.04–1.90) if they were Black and 1.39 (95% CI, 1.03–1.87) if they were White. That is the origin of every "40% higher risk" headline: a relative comparison between two groups, not a probability that attaches to any individual woman.

The intervals are where the story gets more honest. Both lower bounds sit just above 1.0 — 1.04 and 1.03 — which means the same data are compatible with a relative increase of three or four percent, and at the other end with something approaching a doubling. The direction of the finding is firm and consistent across two racially distinct samples, which is not nothing. The magnitude is not pinned down. A point estimate reported without its interval converts a wide range into a fact, and most of the coverage did exactly that.

The paper does offer one absolute-scale translation, and it is the number readers can feel. Among Black women, mean years lived free of coronary heart disease were 18.2 (95% CI, 17.5–18.9) with premature menopause and 19.1 (95% CI, 18.8–19.4) without — a difference of roughly eleven months, with overlapping intervals. A similar pattern appeared among White women. Neither reached statistical significance. Cumulative lifetime risk expressed as a percentage, the figure most readers assume sits behind a phrase like "40% higher lifetime risk," does not appear in the publicly available record of this paper at all.

The design carries a structural consequence that no amount of statistical adjustment can reach. Enrollment required a woman to be between 55 and 69 and free of coronary heart disease. Any woman whose menopause arrived at 37 and whose heart attack arrived at 49 — or who died before 55 of anything at all — is absent by construction. Selection of that kind generally drags an estimate toward the null, so the true association across the whole population could plausibly be larger than 1.4. It also means the phrase "lifetime risk" describes risk remaining from roughly age 60 onward. The fifteen to thirty years immediately after an early menopause, the stretch a 41-year-old reading this coverage most wants explained, went unobserved.

Then there is the direction of the arrow. The investigators are unambiguous that they cannot settle it: the causes of premature menopause are not fully understood, and whether the transition itself injures the vasculature or merely marks an underlying risk profile that was already there remains open. As STAT reported, the study "didn't make a distinction between what could be causing risk and what could be a signal of risk." Pradeep Natarajan, commenting from outside the research group, called premature menopause "an important lifelong signal, which could be incorporated into cardiovascular risk optimization earlier in life." That distinction has teeth, because autoimmune disease, chemotherapy, heavy smoking and inherited variation all shorten reproductive life and independently damage arteries. Adjusting for blood pressure and smoking status measured at age 60 does not undo the three preceding decades of whatever produced both outcomes.

Two smaller boundaries deserve naming. Menopause age was self-reported, meaning women were recalling a final period that had occurred fifteen to thirty years earlier. And the outcome was myocardial infarction alone — not stroke, not heart failure, not arrhythmia — so this is a finding about coronary arteries, not about cardiovascular health in general.

The most consequential number in the paper is not the hazard ratio. Premature menopause occurred in 15.5% of the Black women — 545 of 3,522 — and 4.8% of the White women, 313 of 6,514. Both figures sit well above the roughly 2% usually estimated for premature menopause in the general population, which is a caution about the measurement as much as a finding: menopause age here was self-reported decades after the fact, and outside commentators have flagged that error as a plausible contributor to the elevated rates. The gap between the two groups is large enough to survive a fair amount of that noise; the absolute levels are not. A threefold difference in how often a risk-enhancing event happens will do more population-level damage than a modest difference in what it does once it happens. The authors raise the possibility directly, asking whether the higher frequency of premature menopause among Black women contributes to the known disparities in coronary heart disease, and they do not claim to have answered it. The reasons behind the gap itself — early menarche, birth weight, the cumulative physiological cost of racial stress that researchers call weathering — remain outside what these six cohorts can adjudicate.

What the authors argue from all this is deliberately modest. Their stated conclusion is that premature onset of menopause is "an important risk-enhancing factor for lifetime risk and should be routinely assessed in clinical practice to consider intensification of preventive efforts." In other words: a line in a history that most cardiovascular risk calculators do not currently ask for, and that this analysis suggests belongs there — decades before the risk it flags would otherwise come due.

There is a particular kind of study that is more useful than its own headline, and this is one. The 40 percent is real, it survived adjustment, and it appeared at nearly identical strength in two separate populations — but its confidence intervals reach down to 1.03, and the paper's own absolute translation is about eleven months of heart-disease-free life that did not reach statistical significance. The coverage did not fabricate the number; it simply stopped at the point where the number became interesting, which is the interval around it and the fact that everyone studied had already survived to 55. What survives all of that is still worth carrying: premature menopause looks like a durable, decades-early marker on a chart that would not otherwise show one, and it is three times more common among Black women, which may matter more for population health than the hazard ratio does. It reads as a signal that arrives early enough to be useful, not as a verdict already delivered. — Gale Staff